ATE267867T1 - Chimäre serinproteasen - Google Patents

Chimäre serinproteasen

Info

Publication number
ATE267867T1
ATE267867T1 AT98122481T AT98122481T ATE267867T1 AT E267867 T1 ATE267867 T1 AT E267867T1 AT 98122481 T AT98122481 T AT 98122481T AT 98122481 T AT98122481 T AT 98122481T AT E267867 T1 ATE267867 T1 AT E267867T1
Authority
AT
Austria
Prior art keywords
domain
serine proteases
chimeric
serine protease
chimeric serine
Prior art date
Application number
AT98122481T
Other languages
English (en)
Inventor
Wolfram Bode
Richard Engh
Karl-Peter Hopfner
Robert Huber
Erhard Kopetzki
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE267867T1 publication Critical patent/ATE267867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Facsimile Transmission Control (AREA)
AT98122481T 1997-12-03 1998-11-27 Chimäre serinproteasen ATE267867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97121232 1997-12-03

Publications (1)

Publication Number Publication Date
ATE267867T1 true ATE267867T1 (de) 2004-06-15

Family

ID=8227728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98122481T ATE267867T1 (de) 1997-12-03 1998-11-27 Chimäre serinproteasen

Country Status (6)

Country Link
US (3) US6159722A (de)
JP (1) JP3087746B2 (de)
AT (1) ATE267867T1 (de)
AU (1) AU708674B2 (de)
CA (1) CA2254647C (de)
DE (1) DE59811465D1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115396B2 (en) * 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
DK1399568T3 (da) * 2001-02-01 2006-03-27 Hoffmann La Roche Fremgangsmåde til fremstilling af rekombinant trypsin
US6638503B2 (en) * 2001-11-28 2003-10-28 Maharashtra Association For The Cultivation Of Science Streptomyces megasporus sd5, process for the isolation thereof, novel fibrinolytic enzyme prepared therefrom, process for the production of said enzyme and method of treatment of thrombolytic disorders using said enzyme
US20050074865A1 (en) * 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
EP1539941A4 (de) * 2002-08-27 2006-11-29 Adzyme und deren verwendungen
BRPI0417302A (pt) 2003-12-05 2007-03-06 Compound Therapeutics Inc inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
US20080220049A1 (en) * 2003-12-05 2008-09-11 Adnexus, A Bristol-Myers Squibb R&D Company Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
JP2008505119A (ja) * 2004-06-30 2008-02-21 ネクター セラピューティクス アラバマ，コーポレイション 高分子−第ｉｘ因子部分の抱合体
AU2007325838B2 (en) 2006-11-22 2013-09-19 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
EP2247615B1 (de) 2008-02-14 2014-07-30 Bristol-Myers Squibb Company Zielgerichtete therapeutika auf der basis von egfr gentechnisch hergestellten proteinen
AR071874A1 (es) 2008-05-22 2010-07-21 Bristol Myers Squibb Co Proteinas de dominio de armazon basadas en fibronectina multivalentes
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
CA2817671A1 (en) * 2009-11-17 2011-05-26 Universite De Montreal Heteropeptides useful for reducing nonspecific adsorption
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
EP3091028A1 (de) 2010-05-26 2016-11-09 Bristol-Myers Squibb Company Auf fibronectin basierende gerüstproteine mit erhöhter stabilität
KR102049900B1 (ko) 2012-07-25 2019-11-28 카탈리스트 바이오사이언시즈, 인코포레이티드 변형 인자 x 폴리펩티드 및 이의 용도
AU2015231170B2 (en) 2014-03-20 2019-10-03 Bristol-Myers Squibb Company Serum albumin-binding fibronectin type III domains
US10766946B2 (en) 2015-09-23 2020-09-08 Bristol-Myers Squibb Company Fast-off rate serum albumin binding fibronectin type III domains

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5304631A (en) * 1990-01-16 1994-04-19 University Of Colorado Foundation, Inc. Synthetic helizyme enzymes
DK0439442T3 (da) * 1990-01-25 1996-07-08 Univ Washington Faktor X-LACI-hybridprotein
IL134653A0 (en) * 1997-08-22 2001-04-30 Roche Diagnostics Gmbh Zymogenic protease precursors that can be autocatalytically activated and their use
WO1999010483A2 (de) * 1997-08-22 1999-03-04 Roche Diagnostics Gmbh Autokatalytisch aktivierbare vorstufen von proteasen und deren verwendung

Also Published As

Publication number Publication date
AU708674B2 (en) 1999-08-12
JPH11235173A (ja) 1999-08-31
DE59811465D1 (de) 2004-07-01
US6660492B1 (en) 2003-12-09
JP3087746B2 (ja) 2000-09-11
CA2254647A1 (en) 1999-06-03
US6171842B1 (en) 2001-01-09
AU9605898A (en) 1999-06-24
CA2254647C (en) 2002-07-16
US6159722A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
DE59811465D1 (de) Chimäre Serinproteasen
ES2180024T3 (es) Radio telefono.
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
DK0753057T3 (da) Alkalisk Bacillus-amylase
DE68929484D1 (de) Proteolytische Enzyme und ihre Verwendung in Waschmitteln
NO306458B1 (no) DP-IV-serin proteaseinhibitorer
PT717778E (pt) Serina proteases resistentes a alcalinidade elevada
AU5414000A (en) Compounds
NO20051274L (no) Kledningsplate
DK1135300T4 (da) Dåseende med lille diameter og stor åbning
TR200001878T2 (tr) Hilal şekilli dudakları olan gaga-tipi valf.
ATE259512T1 (de) Tragbares telefon und einschaltverfahren
BR9405351A (pt) Ação combinada de endoglucanases e celobioidrolases
AU7573800A (en) Sleeve for the blade of a knife
ES2090636T3 (es) Un aditivo detergente que contiene una celulasa y una proteasa.
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
DE60132609D1 (de) Optischer isolator mit niedrigen einfügeverlusten
ATE320422T1 (de) Metalloproteinase inhibitoren
ATE479420T1 (de) Orale zusammensetzung mit verbesserten mundhygieneeigenschaften
SE0004850D0 (sv) Shield can
ATE268501T1 (de) Schaltelement, insbesondere druckwellenschalter
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
ES2113761T3 (es) Peroxido de benzoilo desactivado provisionalmente, procedimiento para su preparacion y su utilizacion.
ES2132689T3 (es) Agentes de lavado con celulasa.
DE69129785D1 (de) Monolithisch integrierbarer Schalter mit niedrigem Leistungsverbrauch für Fernsprechapparate und dergleichen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee